Health Condition 1: M256- Stiffness of joint, not elsewhereclassified
Conditions
Interventions
Intervention1: Capsular hydrodilatation: A mixture of Bupivacaine 0.5% (4 ml), triamcinolone (80 mg), Iohexol 2 to 5 ml, and sterile saline to be injected into the glenohumeral joint under CT guidance
Sponsors
Asem Rangita Chanu
Eligibility
Inclusion criteria
Inclusion criteria: a) Patients of either sex aged between 18 and 75 years attending the outpatient clinic of the Department of Physical Medicine & Rehabilitation with complaints of shoulder pain and stiffness for at least 3 months will be screened for eligibility b) Clinical diagnosis of AC made by a thorough history and clinical examination of each shoulder c) Normal plain radiographic appearance and presence of no secondary causes for the patientâ??s complaints d) Patients who receive conservative management (hot fomentation of affected shoulder, Codmanâ??s exercise, Range of Motion exercises and activities of affected shoulder, acetaminophen 650mg when required for pain up to a maximum of 5 tablets a day) for at least 2 weeks with no meaningful relief (less than 50% improvement in the passive range of movement in the affected shoulder for at least two of the three movements: forward flexion, abduction or external rotation).
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in function (SPADI score) of the shoulderTimepoint: 1, 4 and 6 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in passive ROM of the shoulderTimepoint: 1, 4 and 6 weeks;Change in triple-phase bone scan findings of the shoulderTimepoint: 6 weeks;Relationship between ultrasound findings and change in function and passive ROM of the shoulderTimepoint: NA | — |
Countries
India
Contacts
Public ContactAsem Rangita Chanu
All India Institute of Medical Sciences, New Delhi
Outcome results
None listed